A cost-effectiveness analysis of newborn hearing screening strategies

Archives of Pediatrics and Adolescent Medicine

Volumn 154, Issue 5, 2000, Pages 484-488

  Kemper, Alex R ^a,b   Downs, Stephen M ^a  

^a UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; COUNSELING; EARLY DIAGNOSIS; EVOKED BRAIN STEM AUDITORY RESPONSE; EVOKED OTOACOUSTIC EMISSION; FEMALE; HEARING LOSS; HEARING TEST; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL DECISION MAKING; NEWBORN; NEWBORN PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; RISK BENEFIT ANALYSIS; SCREENING;

EID: 0034023347     PISSN: 10724710     EISSN: None     Source Type: Journal    
DOI: 10.1001/archpedi.154.5.484     Document Type: Article

References (38)

1. Screening for hearing impairment US Preventive Services Task Force. In: Guide to Clinical Preventive Services. 2nd ed. Alexandria, Va: International Medical Publishing; 1996:933.
2. Serious hearing impairment among children aged 3-10 years - Atlanta, Georgia, 1991-1993. MMWR Morb Mortal Wkly Rep 1997;46:1073-1076.
3. Healthy People 2000: National Health Promotion and Disease Prevention Objectives. Washington, DC: Public Health Service, US Dept of Health and Human Services; 1990:692.
4. Bess FH, Paradise JL. Universal screening for infant hearing impairment: not simple, not risk-free, not necessarily beneficial, and not presently justified. Pediatrics. 1994;93:330-334.
5. White KR, Maxon AB. Universal screening for infant hearing impairment: simple, beneficial, and presently justified. Int J Pediatr Otorhinolaryngol. 1995;32:201-211.
6. Early identification of hearing impairment in infants and young children. NIH Consens Statement March 1-3, 1993;11:1-24.
7. American Academy of Pediatrics Joint Committee on Infant Hearing. Joint Committee on Infant Hearing 1994 Position Statement. Pediatrics. 1995;95:152-156.
8. National Center for Hearing Assessment and Management. Legislative activity. Available at: http://www.infanthearing.org/legislative/index.html. Accessed July 5, 1999.
9. Davis A, Bamford J, Wilson I, Ramkalawan T, Forshaw M, Wright S. A critical review of the role of neonatal hearing screening in the detection of congenital hearing impairment. Health Technol Assess. 1997;1(10):i-iv, 1-176.
10. Mason JA, Hermann KR. Universal infant hearing screening by automated auditory brainstem response measurement. Pediatrics. 1998;101:221-228.
11. Downs MP, Yoshinaga-Itano C. The efficacy of early identification and intervention for children with hearing impairment. Pediatr Clin North Am. 1999;46:79-87.
12. Yoshinaga-Itano C. Efficacy of early identification and early intervention. Semin Hear. 1995;16:115-123.
13. Robinshaw HM. Early intervention for hearing impairment: differences in the timing of communicative and linguistic development. Br J Audiol. 1995;29:315-334.
14. Luetje CM, Jackson K. Cochlear implants in children: what constitutes a complication? Otolaryngol Head Neck Surg. 1997;117:243-247.
15. Padden C, Ramsey C. Deaf culture and literacy. Am Ann Deaf. 1993;138:96-99.
16. Swanson L. Cochlear implants: the head-on collision between medical technology and the right to be deaf. CMAJ. 1997;157:929-932.
17. Lutman ME, Davis AC, Fortnum HM, Wood S. Field sensitivity of targeted neonatal hearing screening by transient-evoked otoacoustic emissions. Ear Hear. 1997; 18:265-276.
18. Vohr BR, Maxon AB. Screening infants for hearing impairment. J Pediatr. 1996; 128(5, pt 1):710-714.
19. Herrmann BS, Thornton AR, Joseph JM. Automated infant hearing screening using the ABR: development and validation. Am J Audiol. 1995;4:6-14.
20. Maxon AB, White KR, Behrens TR, Vohr BR. Referral rates and cost efficiency in a universal newborn hearing screening program using transient evoked otoacoustic emissions. J Am Acad Audiol. 1995;6:271-277.
21. Lutman ME. Reliable identification of click-evoked otoacoustic emissions using signal-processing techniques. Br J Audiol. 1993;27:103-108.
22. Weirather YP, Korth N, White KR, Downs D, Woods-Kershner N. Cost analysis of TEOAE-based universal newborn hearing screening. J Commun Disord. 1997; 30:477-492.
23. Downs MP. Universal newborn hearing screening: the Colorado story. Int J Pediatr Otorhinolaryngol. 1995;32:257-259.
24. Barsky-Firkser L, Sun S. Universal newborn hearing screenings: a three-year experience. Pediatrics. June 1997;99:e4. Available at: http://www.pediatrics.org/ cgi/content/full/99/6/e4.
25. Sox HC, Blatt MA, Higgins MC, Marton KI. Medical Decision Making. Woburn, Mass: Butterworth-Heinemann; 1988:406.
26. Guyer B, MacDorman MF, Martin JA, Peters KD, Strobino DM. Annual summary of vital statistics-1997. Pediatrics. 1998;102:1333-1349.
27. Finitzo T, Albright K, O'Neal J. The newborn with hearing loss: detection in the nursery. Pediatrics. 1998;102:1452-1460.
28. Mehl AL, Thomson V. Newborn hearing screening: the great omission. Pediatrics. January 1998;101:e4. Available at: http://www.pediatrics.org/cgi/content/ full/101/1/e4.
29. Graham JD, Corso PS, Morris JM, Segui-Gomez M, Weinstein MC. Evaluating the cost-effectiveness of clinical and public health measures. Annu Rev Public Health. 1998;19:125-152.
30. Petitti DB. Meta-analysis, Decision Analysis, and Cost-effectiveness Analysis. New York, NY: Oxford University Press; 1994:246.
31. Guthrie R. The introduction of newborn screening for phenylketonuria: a personal history. Eur J Pediatr. 1996;155(suppl 1):S4-S5.
32. Vohr BR, Carty LM, Moore PE, Letourneau K. The Rhode Island Hearing Assessment Program: experience with statewide hearing screening (1993-1996). J Pediatr. 1998;133:353-357.
33. Ross JA, Severson RK, Pollock BH, Robinson LL. Childhood cancer in the United States. Cancer. 1996;77:201-207.
34. Dick PT, for the Canadian Task Force on the Periodic Health Examination. Periodic health examination, 1996 update, 1: prenatal screening for and diagnosis of Down syndrome. CMAJ. 1996;154:465-479.
35. Sox HC. Benefit and harm associated with screening for breast cancer. N Engl J Med. 1998;338:1145-1146.
36. Paul D. Contesting consent: the challenge to compulsory neonatal screening for PKU. Perspect Biol Med. 1999;42:207-219.
37. Wolf AM, Nasser JF, Wolf AM, Schorling JB. The impact of informed consent on patient interest in prostate-specific antigen screening. Arch Intern Med. 1996; 156:1333-1336.
38. Geller G, Strauss M, Bernhardt BA, Holtzman NA. "Decoding" informed consent: insights from women regarding breast cancer susceptibility testing. Hastings Cent Rep. March-April 1997;27:28-33.